BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND IDH1, IDP, 3417, ENSG00000138413, IDH, PICD, O75874 AND Treatment
23 results:

  • 1. TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort.
    Cruz-Romero SD; González S; Juez JY; Becerra DS; Baldión AM; Hakim JA; González-Devia D; Perdomo S; Rodríguez-Urrego PA
    Adv Ther; 2024 Feb; 41(2):792-805. PubMed ID: 38170436
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Machine learning to improve interpretability of clinical, radiological and panel-based genomic data of glioma grade 4 patients undergoing surgical resection.
    Dal Bo M; Polano M; Ius T; Di Cintio F; Mondello A; Manini I; Pegolo E; Cesselli D; Di Loreto C; Skrap M; Toffoli G
    J Transl Med; 2023 Jul; 21(1):450. PubMed ID: 37420248
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
    Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
    Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Standard or extended STUPP? Optimal duration of temozolomide for patients with high-grade gliomas: a retrospective analysis.
    Wang J; Huang Y; Zhao F; Chen J; He L; Liu Z; Pei Y; Wei Z; Li R; Ai P; Peng X
    J Neurooncol; 2022 Nov; 160(2):433-443. PubMed ID: 36357822
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Radiomic study on preoperative multi-modal magnetic resonance images identifies idh-mutant TERT promoter-mutant gliomas.
    Wang H; Zhang S; Xing X; Yue Q; Feng W; Chen S; Zhang J; Xie D; Chen N; Liu Y
    Cancer Med; 2023 Feb; 12(3):2524-2537. PubMed ID: 36176070
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Low expression of isocitrate dehydrogenase 1 (idh1) R132H is associated with advanced pathological features in laryngeal squamous cell carcinoma.
    Shayanfar N; Zare-Mirzaie A; Mohammadpour M; Jafari E; Mehrtash A; Emtiazi N; Tajik F
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4253-4267. PubMed ID: 36063222
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Luminescent Pyrrole-Based Phosphaphenalene Gold Complexes: Versatile Anticancer Tools with Wide Applicability.
    Fermi V; Regulska E; Wolfram A; Wessling P; Rominger F; Herold-Mende C; Romero-Nieto C
    Chemistry; 2022 Jun; 28(34):e202104535. PubMed ID: 35293640
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. SMARCA4/BRG1-Deficient Sinonasal Carcinoma.
    Kakkar A; Ashraf SF; Rathor A; Adhya AK; Mani S; Sikka K; Jain D
    Arch Pathol Lab Med; 2022 Sep; 146(9):1122-1130. PubMed ID: 34871352
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Genetic analysis of sinonasal undifferentiated carcinoma discovers recurrent SWI/SNF alterations and a novel PGAP3-SRPK1 fusion gene.
    Heft Neal ME; Birkeland AC; Bhangale AD; Zhai J; Kulkarni A; Foltin SK; Jewell BM; Ludwig ML; Pinatti L; Jiang H; McHugh JB; Marentette L; McKean EL; Brenner JC
    BMC Cancer; 2021 May; 21(1):636. PubMed ID: 34051734
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A rapid genotyping panel for detection of primary central nervous system lymphoma.
    Gupta M; Burns EJ; Georgantas NZ; Thierauf J; Nayyar N; Gordon A; Jones SS; Pisapia M; Sun Y; Burns RP; Velarde J; Jordan JT; Frigault MJ; Nahed BV; Jones PS; Barker FG; Curry WT; Gupta R; Batchelor TT; Romero JM; Brastianos PK; Marble HD; Martinez-Lage M; Tateishi K; Lennerz JK; Dietrich J; Cahill DP; Carter BS; Shankar GM
    Blood; 2021 Aug; 138(5):382-386. PubMed ID: 33735913
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Long non-coding RNA TP73-AS1 is a potential immune related prognostic biomarker for glioma.
    Zhang B; Li Q; Wu B; Zhang S; Li L; Jin K; Li S; Li K; Wang Z; Lu Y; Xia L; Sun C
    Aging (Albany NY); 2021 Feb; 13(4):5638-5649. PubMed ID: 33589576
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Radiotherapy-induced glioblastoma: distinct differences in overall survival, tumor location, pMGMT methylation and primary tumor epidemiology in Hong Kong chinese patients.
    Woo PYM; Lee JWY; Lam SW; Pu JKS; Chan DTM; Mak CHK; Ho JMK; Wong ST; Po YC; Lee MWY; Chan KY; Poon WS
    Br J Neurosurg; 2024 Apr; 38(2):385-392. PubMed ID: 33576706
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. TROP-2, 5hmC, and idh1 Expression in Anaplastic Thyroid Carcinoma.
    Seok JY; Astvatsaturyan K; Peralta-Venturina M; Lai J; Fan X
    Int J Surg Pathol; 2021 Jun; 29(4):368-377. PubMed ID: 33289434
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (idh) Mutations.
    Röver LK; Gevensleben H; Dietrich J; Bootz F; Landsberg J; Goltz D; Dietrich D
    EBioMedicine; 2018 Feb; 28():97-104. PubMed ID: 29396294
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. An Interesting Case of Oral Inverted Ductal Papilloma.
    Berridge N; Kumar M
    Dent Update; 2016 Dec; 43(10):950-2. PubMed ID: 29155535
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Frequent idh2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas.
    Dogan S; Chute DJ; Xu B; Ptashkin RN; Chandramohan R; Casanova-Murphy J; Nafa K; Bishop JA; Chiosea SI; Stelow EB; Ganly I; Pfister DG; Katabi N; Ghossein RA; Berger MF
    J Pathol; 2017 Aug; 242(4):400-408. PubMed ID: 28493366
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic value and their clinical implication of 89-gene signature in glioma.
    Shahid M; Cho KM; Nguyen MN; Choi TG; Jo YH; Aryal SN; Yoo JY; Yun HR; Lee JW; Eun YG; Lee JS; Kang I; Ha J; Yoon HJ; Kim SY; Kim SS
    Oncotarget; 2016 Aug; 7(32):51237-51250. PubMed ID: 27323413
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prognostic factors in stage IV oropharyngeal squamous cell carcinoma: the "punto" experience.
    Piccinini A; Alicandri-Ciufelli M; Ghidini A; Vincenti V; Ferri T; Presutti L
    Acta Biomed; 2016 May; 87(1):86-96. PubMed ID: 27163901
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Progression of gingival squamous cell carcinoma from early to late stage after invasive dental procedure.
    Hinchy NV; Jayaprakash V; Rigual N; Reid M; Frustino JL; Rossitto R; Groman A; Sullivan MA
    Gen Dent; 2016; 64(2):38-43. PubMed ID: 26943087
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.